CYP11A1 and polycystic ovary syndrome: In studies comparing normal and PCOS theca cells, determination of endogenous CYP11A1 mRNA half-life by pharmacological inhibition of transcription demonstrated that the half-life of CYP11A1 mRNA is increased two-fold in PCOS theca cells, as compared to normal theca cells.